Galactosylation of serum immunoglobulin G in myasthenia gravis with different autoantibodies

References

• Verschuuren JMG, Palace J, Murai H, et al. Advances and ongoing research in the treatment of autoimmune neuromuscular junction disorders. Lancet Neurol. 2022;21(2):63–64.
   Web of Science ®Google Scholar
• Nikolic A, Djukic P, Basta I, et al. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis. Clin Neurol Neurosurg. 2013;115(4):432–437. doi: 10.1016/j.clineuro.2012.06.013.
   PubMed Web of Science ®Google Scholar
• Lavrnic D, Losen M, Vujic A, et al. The features of myasthenia gravis with autoantibodies to MuSK. J Neurol Neurosurg Psychiatry. 2005;76(8):1099–1102. doi: 10.1136/jnnp.2004.052415.
   PubMed Web of Science ®Google Scholar
• Tsonis AI, Zisimopoulou P, Lazaridis K, et al. MuSK autoantibodies in myasthenia gravis detected by cell based assay – a multinational study. J Neuroimmunol. 2015;284:10–17. doi: 10.1016/j.jneuroim.2015.04.015.
   PubMed Web of Science ®Google Scholar
• Jefferis R, Lund J, Pound JD. IgG-Fc-mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation. Immunol Rev. 1998;163:59–76. doi: 10.1111/j.1600-065x.1998.tb01188.x.
   PubMed Web of Science ®Google Scholar
• Parekh RB, Dwek RA, Sutton BJ, et al. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature. 1985;316(6027):452–457. doi: 10.1038/316452a0.
   PubMed Web of Science ®Google Scholar
• Rademacher TW, Parekh RB, Dwek RA, et al. The role of IgG glycoforms in the pathogenesis of rheumatoid arthritis. Springer Semin Immunopathol. 1988;10(2–3):231–249. doi: 10.1007/BF01857227.
   PubMed Web of Science ®Google Scholar
• Takahashi N, Ishii I, Ishihara H, et al. Comparative structural study of the N-linked oligosaccharides of human normal and pathological immunoglobulin G. Biochemistry. 1987;26(4):1137–1144. doi: 10.1021/bi00378a023.
   PubMed Web of Science ®Google Scholar
• Axford JS. Glycosylation and rheumatic disease. Biochim Biophys Acta. 1999;1455(2–3):219–229. doi: 10.1016/S0925-4439(99)00057-5.
   PubMed Web of Science ®Google Scholar
• Huang C, Liu Y, Wu H, et al. Characterization of IgG glycosylation in rheumatoid arthritis patients by MALDI-TOF-MSn and capillary electrophoresis. Anal Bioanal Chem. 2017;409(15):3731–3739. doi: 10.1007/s00216-017-0302-1.
   PubMed Web of Science ®Google Scholar
• Su Z, Xie Q, Wang Y, et al. Aberrant immunoglobulin G glycosylation in rheumatoid arthritis by LTQ-ESI-MS. Int J Mol Sci. 2020;21(6):2045–2059. doi: 10.3390/ijms21062045.
   PubMed Web of Science ®Google Scholar
• Bond A, Alavi A, Axford JS, et al. The relationship between exposed galactose and N-acetylglucosamine residues on IgG in rheumatoid arthritis (RA), juvenile chronic arthritis (JCA) and Sjӧgren syndrome (SS). Clin Exp Immunol. 1996;105(1):99–103. doi: 10.1046/j.1365-2249.1996.d01-741.x.
   PubMed Web of Science ®Google Scholar
• Zeng X, Li S, Tang S, et al. Changes of serum IgG glycosylation patterns in primary biliary cholangitis patients. Front Immunol. 2021;12:669137. doi: 10.3389/fimmu.2021.669137.
   PubMed Web of Science ®Google Scholar
• Shinzaki S, Kuroki E, Iijima H, et al. Lectin-based immunoassay for aberrant IgG glycosylation as the biomarker for Crohn’s disease. Inflamm Bowel Dis. 2013;19(2):321–331. doi: 10.1097/MIB.0b013e318280eade.
   PubMed Web of Science ®Google Scholar
• Solkiewicz K, Krotkiewski H, Jedryka M, et al. Variability of serum IgG sialylation and galactosylation degree in women with advanced endometriosis. Sci Rep. 2021;11(1):5586–5590.
   PubMed Web of Science ®Google Scholar
• Pilkington C, Yeung E, Isenberg D, et al. Agalactosyl IgG and antibody specificity in rheumatoid arthritis, tuberculosis, ­systemic lupus erythematosus and myasthenia gravis. Autoimmunity. 1995;22(2):107–111. doi: 10.3109/08916939508995306.
   PubMed Web of Science ®Google Scholar
• Selman MHJ, Niks EH, Titulaer MJ, et al. IgG Fc N-glycosylation changes in Lambert-Eaton myasthenic syndrome and myasthenia gravis. J Proteome Res. 2011;10(1):143–152. doi: 10.1021/pr1004373.
   PubMed Web of Science ®Google Scholar
• Mandel-Brehm C, Fichtner ML, Jiang R, et al. Elevated N-linked glycosylation of IgG V regions in myasthenia gravis disease subtypes. J Immunol. 2021;207(8):2005–2014. doi: 10.4049/jimmunol.2100225.
   PubMed Web of Science ®Google Scholar
• De Haan N, Falck D, Wuhrer M. Monitoring of immunoglobulin N- and O-glycosylation in health and disease. Glycobiology. 2020;30(4):226–240. doi: 10.1093/glycob/cwz048.
   PubMed Web of Science ®Google Scholar
• Lis H, Sharon N. Applications of lectins – isolation and structural studies of glycoconjugates. In: Liener IE, Sharon N and Goldstein IJ, editors. The lectins – properties, functions and applications in biology and medicine. New York: Academic Press; 1986. p. 294–309.
   Google Scholar
• Goldstein IJ, Poretz RD. Isolation, physicochemical characterization, and carbohydrate-binding specificity of lectins. In: Liener IE, Sharon N, Goldstein IJ, editors. The lectins – properties, functions and applications in biology and medicine. New York: Academic Press; 1986. p. 35–50.
   Google Scholar
• Bog-Hansen TC, Takeo K. Determination of dissociation constants by affinity electrophoresis: complexes between human serum proteins and concanavalin A. Electrophoresis. 1980;1(1):67–71. doi: 10.1002/elps.1150010112.
   Google Scholar
• Bog-Hansen TC. Affinity electrophoresis with lectins for the study of glycoproteins. Scand J Immunol. 1983;17(10):243–253. doi: 10.1111/j.1365-3083.1983.tb04025.x.
   Google Scholar
• Bond A, Alavi A, Axford JS, et al. A detailed lectin analysis of IgG glycosylation, demonstrating disease specific changes in terminal galactose and N-acetylglucosamine. J Autoimmun. 1997;10(1):77–85. doi: 10.1006/jaut.1996.0104.
   PubMed Web of Science ®Google Scholar
• Saso L, Valentini G, Giardino AM, et al. Changes of glycosylation of serum proteins in psoriatic arthritis, studied by enzyme-linked lectin assay (ELLA), using concanavalin A. Biochem Mol Biol Int. 1998;46(5):867–875. doi: 10.1080/15216549800204412.
   PubMedGoogle Scholar
• Lu G, Holland LA. Profiling the N-glycan composition of IgG with lectins and capillary nanogel electrophoresis. Anal Chem. 2019;91(2):1375–1383. doi: 10.1021/acs.analchem.8b03725.
   PubMed Web of Science ®Google Scholar
• Jaretzki A, Barohn RJ, Ernstoff RM, et al. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology. 2000;55(1):16–23.
   PubMed Web of Science ®Google Scholar
• Dragacevic L, Djordjevic B, Gavrovic-Jankulovic M, et al. ELLSA based profiling of surface glycosylation in microorganisms reveals that β-glucan rich yeasts’ surfaces are selectively recognized with recombinant banana lectin. Glycoconj J. 2020;37(1):95–105. doi: 10.1007/s10719-019-09898-8.
   PubMed Web of Science ®Google Scholar
• Hay FC, Westwood OMR. Two-dimensional or crossed immunoelectrophoresis. In: Hay FC, Westwood OMR, Nelson PN, editors. Practical immunology. 4th ed. Oxford (UK): Blackwell Science; 2002. p. 101–102.
   Google Scholar
• Hajdukovic L, Cuperlovic M. Glycosylation of human IgG examined by lectin affinity immunoelectrophoresis. Arch Biol Sci. 1996;48(1–2):3–4.
   Google Scholar
• Hajdukovic L, Nesic M, Cuperlovic M, et al. A study of human immunoglobulin (IgG and IgE) glycosylation by interaction with lectins. In: Lukic ML, Colic M, Mostarica-Stojkovic M, Cuperlovic K, editors. Immunoregulation in health and disease: experimental and clinical aspects. New York (NY): Academic Press; 1997. p. 221–233.
   Google Scholar
• Parekh R, Roitt I, Isenberg D, et al. Age-related galactosylation of the N-linked oligosaccharides of human serum IgG. J Exp Med. 1988;167(5):1731–1736. doi: 10.1084/jem.167.5.1731.
   PubMed Web of Science ®Google Scholar
• Vanhooren V, Desmyter L, Liu XE, et al. N-glycomic changes in serum proteins during human aging. Rejuvenation Res. 2007;10:521–531. doi: 10.1089/rej.2007.0556.
   PubMed Web of Science ®Google Scholar
• Gudelj I, Lauc G, Pezer M. Immunoglobulin G glycosylation in aging and diseases. Cell Immunol. 2018;333:65–79. doi: 10.1016/j.cellimm.2018.07.009.
   PubMed Web of Science ®Google Scholar
• Bondt A, Selman MHJ, Deelder AM, et al. Association between galactosylation of immunoglobulin G and improvement of rheumatoid arthritis during pregnancy is independent of sialylation. J Proteome Res. 2013;12(10):4522–4531. doi: 10.1021/pr400589m.
   PubMed Web of Science ®Google Scholar
• Kemna MJ, Plomp R, van Paassen P, et al. Galactosylation and sialylation levels of IgG predict relapse in patients with PR3-ANCA associated vasculitis. EBioMedicine. 2017;17:108–118. doi: 10.1016/j.ebiom.2017.01.033.
   PubMed Web of Science ®Google Scholar
• Arrol H, Jefferis R. Antibody and protein glycosylation in health and disease. In: Lukic M, Colic M, Mostarica-Stojkovic M, Cuperlovic K, editors. Immunoregulation in health and disease: experimental and clinical aspects. New York (NY): Academic Press; 1997. p. 115–138.
   Google Scholar
• Papakonstantinou M, Dryllis G, Efstathopoulou M, et al. N-glycosylation of IgG immunoglobulin and its clinical significance. J Biomed. 2019;4:35–43. doi: 10.7150/jbm.33922.
   Google Scholar
• Paton B, Suarez M, Herrero P, et al. Glycosylation biomarkers associated with age-related diseases and current methods for glycan analysis. Int J Mol Sci. 2021;22(11):5788–5827. doi: 10.3390/ijms22115788.
   PubMed Web of Science ®Google Scholar
• Fleming SC, Smith S, Knowles D, et al. Increased sialylation of oligosaccharides on IgG paraproteins – a potential new tumour marker in multiple myeloma. J Clin Pathol. 1998;51(11):825–830. doi: 10.1136/jcp.51.11.825.
   PubMed Web of Science ®Google Scholar
• Wang J, Huang C, Zhou J, et al. Causal link between immunoglobulin G glycosylation and cancer: a potential glycobiomarker for early tumor detection. Cell Immunol. 2021;361:104282. doi: 10.1016/j.cellimm.2021.104282.
   PubMed Web of Science ®Google Scholar
• Matsushita M. The lectin pathway of the complement system. Microbiol Immunol. 1996;40(12):887–893. doi: 10.1111/j.1348-0421.1996.tb01156.x.
   PubMed Web of Science ®Google Scholar